Endexx Expands Cannsumable(C) Portfolio With Launch of CBD Unlimited
April 30 2015 - 7:00AM
Endexx Corporation (OTC: EDXC), a provider of innovative medical
marijuana management and technology solutions, is pleased to
announce the expansion of its Cannsumable© asset portfolio with the
addition and launch of a new proprietary e-commerce site,
CBDUnlimited.com (http://www.cbdunlimited.com/).
Since early 2014, Endexx has secured a high quality supply chain
of imported industrial hemp based Cannabidiol (CBD) extracts and
nutritional products. Endexx has been testing formulations and
delivery systems through volunteers, patients and customers
representing a wide demographic range for important criteria like
usability, effectiveness, taste and overall experience. Significant
feedback was gathered and used to help develop Phyto-Nutrient© rich
solutions for health.
Endexx management and its expert advisors are secure in the
knowledge that its products meet the highest standards of quality
and have demonstrated they deliver distinct benefits to its
targeted audience of health-conscious individuals of all ages.
The Company’s initial product brands are M3CBD© and M3Vape©. Our
mission is to provide Phyto-Nutrients© and Phyto-Delivery© systems
that optimize the efficacy of CBD enriched products derived from
“Eco-Farmed” and organically grown “Industrial Hemp.” The M3CBD©
line of products carries a full, naturally occurring cannabinoid
and terpene profile that stimulates the release of our natural
endocannabinoids and enhances the body’s innate endocannabinoid
response. All products offered carry a Certificate of Analysis
(COA) ensuring the products are toxin and contaminant free and
contain less the .03 percent THC providing a legal alternative to
Medical Marijuana. Multiple products will be introduced to our
customers in the coming months.
CBD Health Solutions LLC, a provider and distributor of
nutraceutical and health related products acquired by Endexx
earlier this year, participated at the Denver Cannabis Cup on April
18-20. Their unique line of products generated strong interest and
overwhelmingly positive feedback, with all products selling out on
the first day of the show.
Here are written testimonials about CBD Health Solutions’
special cannabinoid and terpene rich formulation from visitors at
the Cannabis Cup:
Daniel S. wrote, “The soothing and relaxing effect was
noticeable without a doubt on the very first try. I am thankful to
try this product so I can live with MS (Multiple Sclerosis) without
any trouble. Thank you very much sir. My friend, who was diagnosed
with brain cancer, said that one dropper full was enough, that she
woke up, NOT nauseous and WITHOUT a headache for the first time in
50 days.”
Endexx is rapidly expanding its salesforce for both CBD Health
Solutions LLC., and CBD Unlimited nationwide, reaching new retail
markets every day as Cannabidiol becomes increasingly recognized
and accepted as a natural compound for health. After several months
of market exploration, feedback from vendors has exceeded early
forecasts. Products are selling out rapidly and retailers continue
to increase the size of their orders, as loyal customers return for
more and share their experience to friends and family. Individual
customer testimonies can be found on both websites.
We expect retail sales to grow by 20 to 30 percent per quarter
through 2017. Sales are projected to exceed $1 million in the next
12 months. That is the equivalent of 800,000 daily doses on year
one, enough to supply 2,000 regular patients and users for one
year.
Dylan Trotter of CBD Health Solutions stated, “A majority of
sales came as a result of attendees who sampled our “Canna Joos,”
then came back after trying other CBD products at the show,
ultimately informing us they chose to purchase our Canna Joos due
to its unique taste and the quality of the experience.”
Todd Davis, CEO Endexx, added, “After observing 13 patients and
dozens of individual people try and test the products over the past
year, we have witnessed an alternative health product benefiting
all who have used it. Repeat sales and use are immediate and we
expect strong sales growth from the entire Cannsumable division.
Since acquiring CBD Health Solutions, we have rapidly expanded our
Cannsumable© asset portfolio, increased our sales and sales force
and launched a new e-commerce site which makes it easier to order
products, adds value for our customers, and opens up a new sales
channel. We are thrilled about our progress and are actively
working to increase our retail markets.”
We invite you to visit our sites and partake of our
offerings:
www.cbdunlimited.com
and
www.cbdhealthsolutions.com
About Endexx
Endexx provides innovative medical marijuana management and
technology solutions. Endexx with its collaboration partners and
consultants develops and distributes two consumable product lines
derived from industrial hemp that is organic and naturally rich in
phytocannabinoids. The company has two technology products and
services that launched in 2014 -- the M3hub and the Autospense.
Both products provide essential solutions to promote regulatory
compliance and full accountability through "seed to sale" inventory
management and tracking. Based on principles developed by the
pharmacological industry, the m3hub platform is the first
standardized software solution for tracking pharmaceutical grade
marijuana to maintain compliance with the laws of National and
State governments, and local regulatory bodies, as well as, provide
a smooth transition to the eventual Federal mandates. The
Autospense™ is a high-tech marijuana inventory control and
dispensing machine, which provides up to the minute accounting
details and protects the security of the product as well as the
patient. By automating the dispensing process, Autospense™
increases productivity and reduces costs for marijuana retailers,
while enhancing their service quality by reducing transaction time
for customers. Websites are www.cbdunlimited.com ,
www.cbdhealthsolutions.com , www.endexx.com , www.m3hub.com
.
Safe Harbor Notice
This press release may contain "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995, such as statements relating to financial results and plans
for future development activities, and are thus prospective.
Forward-looking statements include all statements that are not
statements of historical fact regarding intent, belief or current
expectations of the Company, its directors or its officers.
Investors are cautioned that any such forward-looking statements
are not guarantees of future performance and involve risks and
uncertainties, many of which are beyond the Company's ability to
control. Actual results may differ materially from those projected
in the forward-looking statements. Among the factors that could
cause actual results to differ materially from those indicated in
the forward-looking statements are risks and uncertainties
associated with the Company's business and finances in general,
including the ability to continue and manage its growth,
competition, global economic conditions and other factors discussed
in detail in the Company's periodic filings with the Securities and
Exchange Commission. The Company undertakes no obligation to update
any forward-looking statements.
For further investor and media information, contact:
Endexx Corporation
Todd Davis
Chairman & CEO
endexx@endexx.com
480-595-6900
or
Irth Communications, LLC.
310-220-4294
Endexx (PK) (USOTC:EDXC)
Historical Stock Chart
From Dec 2024 to Jan 2025
Endexx (PK) (USOTC:EDXC)
Historical Stock Chart
From Jan 2024 to Jan 2025